Cargando...
New Therapeutic Options for the Treatment of Sickle Cell Disease
Sickle cell disease (SCD; ORPHA232; OMIM # 603903) is a chronic and invalidating disorder distributed worldwide, with high morbidity and mortality. Given the disease complexity and the multiplicity of pathophysiological targets, development of new therapeutic options is critical, despite the positiv...
Gardado en:
| Publicado en: | Mediterr J Hematol Infect Dis |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Università Cattolica del Sacro Cuore
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6328043/ https://ncbi.nlm.nih.gov/pubmed/30671208 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2019.002 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|